Check out your Company Bowl for anonymous work chats.
With nearly 30% of #hcp interactions conducted through #digital channels, #pharma cannot afford to be without a blended customer engagement model. Our latest article (https://bit.ly/3cFHX0Y) includes the newest research confirming remote engagement to be vital for effective HCP engagement alongside an example of how a $1.3M investment in hybrid representatives delivered an additional $31M in #sales (a 24:1 return) for our Client. Click the article link below to read: https://blog.amplity.com/thought-leadership/the-resounding-call-for-blended-customer-engagement-models
Understanding why #HCPs choose to discontinue prescribing a drug – your own or your competitors – is critical to a well-informed strategy. Our #Discontinuation Report helps Pharma’s #Clinical, #Commercial, #HEOR, and Data and Analytics teams at all stages of their product lifecycle to inform launch plans, help to refine product messaging, and assists in properly educating patients and HCPs alike. Learn more at https://lnkd.in/eMuus_SR
Introducing Amplity's Market Access Team - Steve Riddle
ONLINE WEBINAR June 23, 2022 / 1:00 PM EST Don’t wait to register for next Thursday’s webinar hosted by Amplity’s #VA Market Access practice lead (former VA VISN Pharmacy Executive), Jann Carmichael, PharmD. We’re reviewing the intricacies of the VA’s unique value (outcomes/cost) perception and sharing tips on how to navigate their complex healthcare system. Register here: https://hubs.ly/Q01dQL730
Precision Medicine plays a vital role in identifying appropriate patients for new therapies. Meet Ken Ruppel and Julie Harrell at #PMWC2022 to learn how we can help develop a launch strategy that aligns, operationalizes, and optimizes components of a #diagnostic to its therapy that increases testing rates and drives brand awareness. Schedule time to meet us before, on-site, or after the conference here https://hubs.ly/Q01dQG220. #precisionmedicine
Amplity’s biopharma and device clients continuously turn to us for expert payer engagement strategy. We are trusted to develop and fully execute plans that establish strong, value-based relationships with payers on behalf of our clients. Managing these sophisticated relationships takes an incredibly skilled, tenured team of marketaccess experts who remain aware of the rapidly evolving payer landscape. We’re thrilled to announce the expansion of our National Account team with the appointment of Todd Hood, Bruce Valentine, and Tomas Andrade. Read the full release at amplity.com/news
Amplity can help your organization uncover and truly understand treatment changes, adverse events, and patient-reported outcomes. Parris Abney is attending #DIAGlobal Annual Meeting to share how we can help your brand gain new #insights with real-world #patientdata and create new opportunities for differentiated provider messaging and #patienteducation. Meet us at booth #1056 or schedule time to meet before, on-site, or after the conference here https://hubs.ly/Q01dq-jz0
ONLINE WEBINAR Federal Market Access Navigating New VA Market Dynamics How to reframe the VA "value" proposition to ensure success in 2022 June 23, 2022 / 1:00 PM EST In this webinar, we'll review the intricacies of the VA's unique value perception and share tips on how to navigate their complex healthcare structure, formulary process, national versus regional, and local implementation; data collection; all to demonstrate how the VA perceives "value" and how you can address it successfully. Register now at https://bit.ly/3aFUfp5
Our Capability Development team stands in solidarity with the #LTEN mission to build communities and cultures of learning. We’re attending the #LTEN2022 conference to share our best practices around building customized learning journeys unique to the challenges of development goals for contributors, management, and/or teams. Schedule time to meet with Jim Heim & Chuck Petrozzini in advance, here https://hubs.ly/Q01djxJ60
Join Amplity’s #Insights leaders Joe Turner and Parris Abney for an ONLINE WEBINAR on WHY it’s critical to know which variables impact HCP treatment decisions surrounding #discontinuation throughout the lifecycle of your product or a competitor's product. Whether you’re planning your launch messaging, optimizing your current messaging, educating patients, or simply interested in discontinuation drivers, we can help you understand the WHY behind #treatmentdecisions. Register here https://hubs.ly/Q01ddXM40
